Tag: Calcitonin gene-related peptide receptor antagonists

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Calcitonin gene-related peptide receptor antagonists

Latest FDA-Approved Preventive Treatment For Migraine, Qulipta, Enters A Highly ... - Forbes

Added to Collection on: 2021-10-03 17:37:30

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Migraine Drug Shows Benefit for Those With Comorbid Depression, Anxiety | MedPage Today

Added to Collection on: 2021-11-02 01:29:48

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Biohaven Partners with Pfizer to Market Migraine Drug | BioSpace

Added to Collection on: 2021-11-09 21:53:29

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Biohaven and Pfizer Complete Collaboration Transaction for Commercialization of ... - PR Newswire

Added to Collection on: 2022-01-05 18:16:14

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Pfizer and Biohaven's VYDURA® (Rimegepant) Granted First Ever Marketing Authorization ...

Added to Collection on: 2022-04-28 13:51:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Pfizer will acquire Biohaven - Zenopa

Added to Collection on: 2022-05-12 08:20:11

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Biohaven's zavegepant nasal spray set to reach projected worth of $206.8m in 2030

Added to Collection on: 2022-05-26 16:34:36

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Vaccine Breaking News - Precision Vaccinations

Added to Collection on: 2022-09-20 12:24:33

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
New Kids on the Block for Migraine Treatment and Prophylaxis - Medscape

Added to Collection on: 2023-10-17 17:32:12

Tags for this article:

Click the tags to see associated articles and topics

View Article Details